Conclusions: This study reveals that ARB is safe and reduces low-grade albuminuria in normotensive renal transplant recipients. Thus, early treatment of ARB in recipients with low-grade albuminuria may prevent cardiovascular disease after renal transplantation.
PMID: 21240871 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)